← Back to directory

Petr Janský

Researcher Next ID · RN-009640

Researcher · Medicine

University Hospital Plzen

, Czechia

Not currently recruitingFunding unknown
Works count
109
Citation count
24,335
H-index
35
i10-index
53

Research interests

Medicine
Atrial Fibrillation Management and Outcomes
Acute Myocardial Infarction Research
Antiplatelet Therapy and Cardiovascular Diseases
Acute Ischemic Stroke Management
Venous Thromboembolism Diagnosis and Management

Publications

  • Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

    The Lancet · 2019 · 10.1016/s0140-6736(19)31149-3

  • Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease

    New England Journal of Medicine · 2016 · 10.1056/nejmoa1600176

  • Apixaban versus Warfarin in Patients with Atrial Fibrillation

    New England Journal of Medicine · 2011 · 10.1056/nejmoa1107039

  • Apixaban in Patients with Atrial Fibrillation

    New England Journal of Medicine · 2011 · 10.1056/nejmoa1007432

  • Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome

    New England Journal of Medicine · 2011 · 10.1056/nejmoa1105819

Current projects

    No projects listed.